News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Proxima Therapeutics Release: Study Indicates That MammoSite Offers Significant Advantages Over Conventional Radiation Boost Therapy For Breast Cancer


10/19/2005 5:11:18 PM

Study results presented at the Annual Meeting of the American Brachytherapy Society in Barcelona, Spain, show that the MammoSite Radiation Therapy System (RTS) is potentially a more efficient way to deliver a boost of radiation to a breast tumor site following whole breast external beam radiation. In the study, researchers compared MammoSite to electron radiotherapy, currently the method most often used to deliver a boost of radiation. According to the results of a 2001 study published in the New England Journal of Medicine, an electron boost dose of radiation following a lumpectomy and whole breast external beam radiation is particularly important for high risk breast cancer patients, reducing local recurrence rates by 48% in women younger than 40.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES